-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Sonnet BioTherapeutics Holdings, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q4 2011 to Q3 2023.
- Sonnet BioTherapeutics Holdings, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending September 30, 2023 was $62.4K, a 13.5% decline year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)